SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-062724
Filing Date
2021-11-03
Accepted
2021-11-03 16:48:31
Documents
1
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3242
  Complete submission text file 0001209191-21-062724.txt   4630
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address
Andersen Jill (Reporting) CIK: 0001891047 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40703 | Film No.: 211376216